PropertyValue
?:abstract
  • The outbreak of pandemic COVID-19 causes severe damage to the human world, including infections, deaths, and economic disruptions The world has focused on developing treatment and controlling measures against COVID-19 Currently, there is no specific approved therapy or medication for the disease, therefore this pandemic situation demonstrates the immediate need for wide-ranging antiviral countermeasures to SARS-CoV-2 and future coronaviruses This article provides an overview of the structure, virology, symptoms, life cycle, and routes of transmission of SARS-CoV-2 The therapeutic effect of two drugs that are regarded to show therapeutic potential [i e , remdesivir (RDV) and favipiravir (FPV)] against COVID-19 are discussed based on the current published data This review can serve as a reference for future studies
is ?:annotates of
?:creator
?:journal
  • ChemBioChem
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Tackling SARS-CoV-2 Infections using Remdesivir and Favipiravir as Therapeutic Options
?:type
?:who_covidence_id
  • #838763
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/kr5kppzr>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/kr5kppzr>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all